Pauline Brice
About
Pauline Brice is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Pauline Brice has authored 192 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Pathology and Forensic Medicine, 97 papers in Oncology and 49 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pauline Brice's work include Lymphoma Diagnosis and Treatment (162 papers), Viral-associated cancers and disorders (61 papers) and Chronic Lymphocytic Leukemia Research (45 papers). Pauline Brice is often cited by papers focused on Lymphoma Diagnosis and Treatment (162 papers), Viral-associated cancers and disorders (61 papers) and Chronic Lymphocytic Leukemia Research (45 papers). Pauline Brice collaborates with scholars based in France, Belgium and United States. Pauline Brice's co-authors include Corinne Haïoun, Éric Lepage, Hervé Tilly, Bertrand Coiffier, Nicole Brousse, Gilles Salles, Christian Gisselbrecht, Y Bastion, Philippe Solal‐Céligny and Josette Brière and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Pauline Brice
185 papers receiving 7.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pauline Brice France | 48 | 6.3k | 5.0k | 2.1k | 2.0k | 1.2k | 192 | 8.1k | ||
| Umberto Vitolo Italy | 51 | 7.3k 1.2× | 4.2k 0.8× | 2.2k 1.1× | 2.5k 1.2× | 951 0.8× | 294 | 9.0k | ||
| Éric Van Den Neste Belgium | 18 | 5.5k 0.9× | 4.2k 0.9× | 1.6k 0.8× | 2.0k 1.0× | 926 0.8× | 46 | 7.2k | ||
| Jan Walewski Poland | 31 | 4.6k 0.7× | 4.2k 0.9× | 1.4k 0.7× | 1.9k 1.0× | 913 0.8× | 214 | 7.0k | ||
| Martin Dreyling Germany | 52 | 10.3k 1.6× | 7.2k 1.4× | 2.2k 1.1× | 4.8k 2.4× | 1.6k 1.4× | 396 | 13.1k | ||
| Stefano Luminari Italy | 35 | 4.3k 0.7× | 2.6k 0.5× | 1.3k 0.6× | 1.2k 0.6× | 602 0.5× | 216 | 5.6k | ||
| Bernd Metzner Germany | 36 | 3.4k 0.5× | 2.9k 0.6× | 1.0k 0.5× | 1.6k 0.8× | 682 0.6× | 126 | 5.6k | ||
| Réda Bouabdallah France | 34 | 5.7k 0.9× | 4.3k 0.9× | 1.5k 0.7× | 2.4k 1.2× | 1.6k 1.4× | 126 | 8.2k | ||
| Marco Ladetto Italy | 42 | 4.2k 0.7× | 2.9k 0.6× | 952 0.5× | 1.7k 0.8× | 1.2k 1.0× | 175 | 7.2k | ||
| Philippe Solal‐Céligny France | 39 | 4.5k 0.7× | 4.3k 0.9× | 695 0.3× | 2.7k 1.3× | 1.9k 1.6× | 109 | 8.7k | ||
| Félix Reyes France | 25 | 5.5k 0.9× | 3.7k 0.7× | 1.7k 0.8× | 2.1k 1.0× | 1.1k 1.0× | 56 | 7.5k |
Countries citing papers authored by Pauline Brice
Since
Specialization
Citations
This map shows the geographic impact of Pauline Brice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pauline Brice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pauline Brice more than expected).
Fields of papers citing papers by Pauline Brice
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Pauline Brice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pauline Brice. The network helps show where Pauline Brice may publish in the future.
Co-authorship network of co-authors of Pauline Brice
This figure shows the co-authorship network connecting the top 25 collaborators of Pauline Brice. A scholar is included among the top collaborators of Pauline Brice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pauline Brice. Pauline Brice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Molinari, Nicolas, David Sibon, Anne‐Ségolène Cottereau, et al.. (2023). Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA . British Journal of Haematology. 202(2). 379–383.
2.
Zinzani, Pier Luigi, Armando Santoro, Giuseppe Gritti, et al.. (2023). Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up. Blood Advances. 7(18). 5272–5280.
3.
Armand, Philippe, Pier Luigi Zinzani, Hun Ju Lee, et al.. (2023). Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma. Blood. 142(10). 878–886.
4.
Casulo, Carla, Jesse G. Dixon, Fang‐Shu Ou, et al.. (2021). Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials. Blood Advances. 5(6). 1737–1745.
5.
Masson, Adèle de, Constance de Margerie‐Mellon, É. de Kerviler, et al.. (2021). Image‐guided lymph node core‐needle biopsy predicts survival in mycosis fungoides and Sézary syndrome*. British Journal of Dermatology. 185(2). 419–427.
6.
Kersten, Marie José, Josée M. Zijlstra, Wouter J. Plattel, et al.. (2020). Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica. 106(4). 1129–1137.
7.
Bouaziz, Jérôme, Maxime Battistella, Jacqueline Rivet, et al.. (2020). Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma. Acta Dermato Venereologica. 100(15). adv00229–adv00229.
8.
Chen, Robert, Pier Luigi Zinzani, Michelle A. Fanale, et al.. (2017). Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma. Journal of Clinical Oncology. 35(19). 2125–2132.
9.
Bachy, Emmanuel, Roch Houot, F. Morschhauser, et al.. (2013). Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma. Haematologica. 98(7). 1107–1114.
10.
Molina, Thierry Jo, et al.. (2013). Autoimmune Hemolytic Anemia and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Association. SHILAP Revista de lepidopterología. 2013. 1–5.
11.
Demeestere, Isabelle, Pauline Brice, Fedro A. Peccatori, et al.. (2012). Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized Trial. Journal of Clinical Oncology. 31(7). 903–909.
12.
Delarue, Richard, Corinne Haïoun, Vincent Ribrag, et al.. (2012). CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte. Blood. 121(1). 48–53.
13.
Colombat, P, Nicole Brousse, Gilles Salles, et al.. (2012). Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. Annals of Oncology. 23(9). 2380–2385.
14.
Sebban, Catherine, Pauline Brice, Richard Delarue, et al.. (2008). Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study. Journal of Clinical Oncology. 26(21). 3614–3620.
15.
Ribrag, Vincent, Serge Koscielny, Olivier Casasnovas, et al.. (2008). Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. Blood. 113(14). 3307–3313.
16.
Salles, Gilles, Nicolas Mounier, Sophie de Guibert, et al.. (2008). Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study. Blood. 112(13). 4824–4831.
17.
Morschhauser, Franck, Pauline Brice, Christophe Fermé, et al.. (2008). Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/Refractory Hodgkin's Lymphoma: Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study Group. Journal of Clinical Oncology. 26(36). 5980–5987.
18.
Sebban, Catherine, Nicolas Mounier, Nicole Brousse, et al.. (2006). Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Blood. 108(8). 2540–2544.
19.
Brice, Pauline, Y Bastion, Marine Diviné, et al.. (1996). Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients. Cancer. 78(6). 1293–1299.
20.
Trédaniel, Jean, Pauline Brice, Éric Lepage, et al.. (1992). The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas. European Respiratory Journal. 5(2). 170–173.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Umberto Vitolo Breakdown of academic impact, for papers by Éric Van Den Neste Breakdown of academic impact, for papers by Jan Walewski Breakdown of academic impact, for papers by Martin Dreyling Breakdown of academic impact, for papers by Stefano Luminari Breakdown of academic impact, for papers by Bernd Metzner Breakdown of academic impact, for papers by Réda Bouabdallah Breakdown of academic impact, for papers by Marco Ladetto Breakdown of academic impact, for papers by Philippe Solal‐Céligny Breakdown of academic impact, for papers by Félix Reyes